A role for CXCR2 in senescence, but what about in cancer?

Juan C Acosta1, Jesús Gil

  • 1Cell Proliferation Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Campus, London, United Kingdom.

Cancer Research
|March 12, 2009
PubMed

Insights

Cellular senescence, a tumor suppressor mechanism, is regulated by the receptor CXCR2. Chemokines IL-8 and GROalpha signaling via CXCR2 may limit early tumor growth by promoting senescence.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Immunology

Background:

  • Senescence is a critical cellular process that acts as a tumor suppressor mechanism, preventing uncontrolled cell proliferation.
  • Oncogene-induced senescence is observed in early-stage tumors but is often lost in advanced malignancies, indicating a complex role in tumorigenesis.
  • The chemokine receptor CXCR2 and its ligands, such as interleukin (IL)-8 and GROalpha, are implicated in both cancer progression and immune responses.

Purpose of the Study:

  • To investigate the role of the chemokine receptor CXCR2 in regulating cellular senescence, particularly oncogene-induced senescence.
  • To explore how signaling through CXCR2 by chemokines IL-8 and GROalpha influences the senescence response during early tumorigenesis.

Main Methods:

  • Experimental depletion of the CXCR2 receptor in cellular models.
  • Assessment of replicative senescence and response to oncogenic signals following CXCR2 modulation.
  • Analysis of the impact of IL-8 and GROalpha signaling on senescence induction and tumor suppression.

Main Results:

  • Depletion of CXCR2 significantly delays the onset of replicative senescence.
  • Impairment of CXCR2 signaling hinders the cellular response to oncogenic signals, suggesting a role in preventing oncogene-induced senescence.
  • Signaling via IL-8 and GROalpha through CXCR2 appears to reinforce senescence, potentially limiting early tumor development.

Conclusions:

  • The CXCR2 receptor plays a crucial role in regulating both replicative and oncogene-induced senescence.
  • Signaling by IL-8 and GROalpha mediated by CXCR2 may function as an early tumor suppressor mechanism by promoting senescence.
  • Further research is needed to reconcile the pro-senescence effects of CXCR2 signaling with its known pro-tumorigenic roles in later stages of cancer.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...